Within its Life Sciences practice, REVERA Law Group has prepared a structured review of 15 legislative changes in the field of pharmaceuticals and healthcare adopted at the EAEU level in 2025.
The overview consolidates all key changes of 2025 in a single document and enables readers to:
This information will be of interest to all stakeholders in the medical and healthcare market of the Republic of Belarus, as well as to foreign companies considering Belarus as a jurisdiction in which to conduct business.
Authors of the material and the overview: Sergey Suschenya, Denis Valukevich and Iryna Navitskaya.